Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin

Clinical-benefit response in advanced non-small-cell lung cancer: A multicentre prospective randomised phase III study of single agent gemcitabine versus cisplatin–vindesine

Published:2001-09 Issue:9 Volume:12 Page:1221-1230
ISSN:0923-7534
Container-title:Annals of Oncology
language:en
Short-container-title:Annals of Oncology

Author:

Vansteenkiste J.F.,Vandebroek J.E.,Nackaerts K.L.,Weynants P.,Valcke Y.J.,Verresen D.A.,Devogelaere R.C.,Marien S.A.,Humblet Y.P.,Dams N.L.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Link

http://academic.oup.com/annonc/article-pdf/12/9/1221/19479759/12-9-1221.pdf

Reference33 articles.

1. Polychemotherapy in advanced non-small-cell lung cancer A meta-analysis;Souquet;Lancet,1993

2. Chemotherapy for advanced non-small-cell lung cancer How much benefit is enough?;Grilli;J Clin Oncol,1993

3. Chemotherapy vs supportive care in advanced non-small-cell lung cancer Results of a meta-analysis of the literature;Marino;Chest,1994

4. A meta-analysis using updated data on individual patients from 52 randomised clinical trials;BMJ,1995

5. Single-agent activity of weekly gemcitabine in advanced non-small-cell lung cancer A phase II study;Anderson;J Clin Oncol,1994

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Ribonucleotide reductase: Implications of thiol S-nitrosylation and tyrosine nitration for different subunits;Nitric Oxide;2022-10

2. Phase III study of adjuvant gemcitabine compared with adjuvant uracil-tegafur in patients with completely resected pathological stage IB–IIIA non-small cell lung cancer (WJTOG0101);International Journal of Clinical Oncology;2021-08-31

3. Symptomlinderung durch Tumortherapie?;Der Schmerz;2018-02-06

4. Frontline Systemic Therapy Options in Nonsmall Cell Lung Cancer;IASLC Thoracic Oncology;2018

5. Measurement of health-related quality of life during chemotherapy – the importance of timing;Acta Oncologica;2017-01-24